zolgensma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /stay-informed/thank-you/ Disallow: /unsubscribe Disallow: /Error/NotFound404/ Disallow: /conference/ Disallow: /conference/thank-you/ Disallow: /stay-informed-post-treatment/ Disallow: /stay-informed-post-treatment/thank-you/ Disallow: | ||
Meta Tags
| Title | ZOLGENSMA® (onasemnogene |
| Description | 3,000+ Learn about ZOLGENSMA, a gene therapy for children less than 2 years old with spinal muscular atrophy. See Full Safety & Prescribing |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.173.36.83 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
zolgensma.com Valuation
|
US$36,421,739
Last updated: 2023-04-26 21:08:06
zolgensma.com has Semrush global rank of 290,604. zolgensma.com has an estimated worth of US$ 36,421,739, based on its estimated Ads revenue. zolgensma.com receives approximately 4,202,509 unique visitors each day. Its web server is located in United States, with IP address 52.173.36.83. According to SiteAdvisor, zolgensma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$36,421,739 |
| Daily Ads Revenue | US$33,621 |
| Monthly Ads Revenue | US$1,008,603 |
| Yearly Ads Revenue | US$12,103,225 |
| Daily Unique Visitors | 280,168 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| zolgensma.com. | A | 86399 | IP: 52.173.36.83 |
| zolgensma.com. | NS | 1800 | NS Record: a2-66.akam.net. |
| zolgensma.com. | NS | 1800 | NS Record: a1-254.akam.net. |
| zolgensma.com. | NS | 1800 | NS Record: a7-64.akam.net. |
| zolgensma.com. | NS | 1800 | NS Record: a24-65.akam.net. |
| zolgensma.com. | NS | 1800 | NS Record: dns4.novartis.com. |
| zolgensma.com. | NS | 1800 | NS Record: a28-67.akam.net. |
| zolgensma.com. | NS | 1800 | NS Record: a9-65.akam.net. |
| zolgensma.com. | NS | 1800 | NS Record: dns2.novartis.com. |
| zolgensma.com. | NS | 1800 | NS Record: dns1.novartis.com. |
| zolgensma.com. | NS | 1800 | NS Record: dns3.novartis.com. |
| zolgensma.com. | TXT | 86400 | TXT Record: prod-zolgensma.azurewebsites.net |
| zolgensma.com. | TXT | 86400 | TXT Record: mk5ssbr2fcu2ha5a5c6cegee7n |
| zolgensma.com. | TXT | 86400 | TXT Record: google-site-verification=tHQxthRnqrgpWjNoKj321JPy_dXm_NLF0J-TDoU0roI |
HtmlToTextCheckTime:2023-04-26 21:08:06
| This website is intended for US audiences only. OneGene Program 855-441-GENE (4363) Prescribing Information For Healthcare Professionals This website is intended for US audiences only. OneGene Program 855-441-GENE (4363) Important Safety Information Prescribing Information For Healthcare Professionals About SMA What Is SMA? SMA Signs and Symptoms SMA Progression SMA Community About ZOLGENSMA What Is ZOLGENSMA? How ZOLGENSMA Works Family Videos ZOLGENSMA Results Steps to ZOLGENSMA Steps to Treatment OneGene Program ZOLGENSMA Resources ZOLGENSMA Downloads Every Day With SMA Daily Life Memorable Moments SMA Care and Milestones Advocacy and Progress Sign Up For Healthcare Professionals Watch family videos Target the genetic root cause of SMA with a one-time infusion Watch how it works 3,000+ children with SMA have been treated with ZOLGENSMA as of January 2023 * . * Globally including clinical trials, commercially, and through the managed access programs. Eli, treated at ~4 months and |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 145 Content-Type: text/html; charset=UTF-8 Location: https://zolgensma.com/ Server: Microsoft-IIS/10.0 X-Powered-By: ASP.NET Set-Cookie: ARRAffinity=e32e571ced514eba02436593f08a92c95dc3b7a342ac31823b58baf4b04f283e;Path=/;HttpOnly;Domain=zolgensma.com Date: Wed, 20 Oct 2021 07:58:09 GMT HTTP/2 301 content-length: 149 content-type: text/html; charset=UTF-8 location: https://www.zolgensma.com/ server: Microsoft-IIS/10.0 x-powered-by: ASP.NET set-cookie: ARRAffinity=e32e571ced514eba02436593f08a92c95dc3b7a342ac31823b58baf4b04f283e;Path=/;HttpOnly;Secure;Domain=zolgensma.com set-cookie: ARRAffinitySameSite=e32e571ced514eba02436593f08a92c95dc3b7a342ac31823b58baf4b04f283e;Path=/;HttpOnly;SameSite=None;Secure;Domain=zolgensma.com date: Wed, 20 Oct 2021 07:58:10 GMT HTTP/2 200 content-length: 0 content-type: text/html; charset=utf-8 server: Kestrel x-powered-by: ASP.NET set-cookie: ARRAffinity=e32e571ced514eba02436593f08a92c95dc3b7a342ac31823b58baf4b04f283e;Path=/;HttpOnly;Secure;Domain=www.zolgensma.com set-cookie: ARRAffinitySameSite=e32e571ced514eba02436593f08a92c95dc3b7a342ac31823b58baf4b04f283e;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.zolgensma.com date: Wed, 20 Oct 2021 07:58:10 GMT |
zolgensma.com Whois Information
Domain Name: ZOLGENSMA.COM Registry Domain ID: 2158760070_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-04-06T22:38:31Z Creation Date: 2017-08-31T22:59:06Z Registry Expiry Date: 2023-08-31T22:59:06Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-08T16:08:03Z <<< |